Drug Name: Depemokimab-ulaa

Brand Name: EXDENSUR® ^[2]

Medicine Use: Add-on therapy/long-term control

Type of Medicine: Biologic

Form: Injection

Prescribing Info: EXDENSUR (depemokimab-ulaa) injection prescribing information insert ^[3]

Note: EXDENSUR is the first ultra-long-acting biologic approved for asthma. While most biologics are given every 2 to 4 weeks, EXDENSUR is given only twice a year (once every 6 months).

Possible Side Effects:
Allergic reaction
Upper respiratory tract infection (common cold, sinus infection)
Sneezing, nasal congestion, runny nose, and nasal itching (allergic rhinitis)
Flu or flu-like symptoms
Joint pain
Sore throat

Copay Assistance Programs for EXDENSUR

If you have commercial insurance: If you have a commercial medical or prescription insurance plan, you may be able to take part on the EXDENSUR Copay Program ^[4]. If you are approved, the GSK Copay Program may help with your cost share for EXDENSUR, as well as provide access to ongoing patient support from a Patient Navigator.

If you have government insurance or no insurance: You are not eligible for this program if you are covered by any federal or state prescription insurance program.

For more information, visit the EXDENSUR Copay Program ^[4] website or call 888-216-3003.

Coverage Support

GSK can help check your insurance coverage and help you understand your benefits. You can reach out to a Patient Navigator at 844-225-5894 ^[5] (844-Call-TwGSK). ^[5]